CompaniesCadent Therapeutics

Cadent Therapeutics

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (3)

Total Trials

3

As Lead Sponsor

3

As Collaborator

0

Total Enrollment

128

By Phase

PHASE2: 2PHASE1: 1

By Status

COMPLETED: 2WITHDRAWN: 1

Clinical Trials Pipeline3 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2018

2019

2020

2021

2022

2023

Today

Hover over trial bars to see details

Recent Trials

NCT04301284Lead Sponsor

Study of CAD-1883 for Spinocerebellar Ataxia

PHASE2Withdrawn

Started: Jun 30, 2021 · Completed: Dec 31, 2022

NCT04306146Lead Sponsor

Study of CAD-9303 in Subjects With Schizophrenia

PHASE1Completed

103 participants

Started: Feb 28, 2020 · Completed: Nov 24, 2021

NCT03688685Lead Sponsor

A Clinical Study to Evaluate CAD-1883 in Essential Tremor

PHASE2Completed

25 participants

Started: Jan 23, 2019 · Completed: Sep 24, 2019

Related Companies

Novartis

acquired